These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38066031)

  • 1. Reproducible and clinically translatable deep neural networks for cervical screening.
    Ahmed SR; Befano B; Lemay A; Egemen D; Rodriguez AC; Angara S; Desai K; Jeronimo J; Antani S; Campos N; Inturrisi F; Perkins R; Kreimer A; Wentzensen N; Herrero R; Del Pino M; Quint W; de Sanjose S; Schiffman M; Kalpathy-Cramer J
    Sci Rep; 2023 Dec; 13(1):21772. PubMed ID: 38066031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REPRODUCIBLE AND CLINICALLY TRANSLATABLE DEEP NEURAL NETWORKS FOR CANCER SCREENING.
    Ahmed SR; Befano B; Lemay A; Egemen D; Rodriguez AC; Angara S; Desai K; Jeronimo J; Antani S; Campos N; Inturrisi F; Perkins R; Kreimer A; Wentzensen N; Herrero R; Del Pino M; Quint W; de Sanjose S; Schiffman M; Kalpathy-Cramer J
    Res Sq; 2023 Mar; ():. PubMed ID: 36909463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
    Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
    Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
    Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
    Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
    BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
    Catarino R; Vassilakos P; Scaringella S; Undurraga-Malinverno M; Meyer-Hamme U; Ricard-Gauthier D; Matute JC; Petignat P
    PLoS One; 2015; 10(7):e0134309. PubMed ID: 26222772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia.
    Murillo R; Gamboa O; Hernández G; González M; Olejua P; Molano M; Wiesner C
    Prev Med; 2021 Dec; 153():106801. PubMed ID: 34508733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].
    Dumont A; Bessières N; Razafindrafara G; Ravit M; Benbassa A
    Rev Epidemiol Sante Publique; 2019 Apr; 67(2):120-125. PubMed ID: 30448093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.
    Lamin H; Eklund C; Elfström KM; Carlsten-Thor A; Hortlund M; Elfgren K; Törnberg S; Dillner J
    BMJ Open; 2017 May; 7(5):e014788. PubMed ID: 28566363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.
    Baena A; Mesher D; Salgado Y; Martínez S; Villalba GR; Amarilla ML; Salgado B; Flores B; Bellido-Fuentes Y; Álvarez-Larraondo M; Valls J; Lora O; Virreira-Prout G; Figueroa J; Turcios E; Soilán AM; Ortega M; Celis M; González M; Venegas G; Terán C; Ferrera A; Mendoza L; Kasamatsu E; Murillo R; Wiesner C; Broutet N; Luciani S; Herrero R; Almonte M;
    Int J Cancer; 2023 Apr; 152(8):1581-1592. PubMed ID: 36451311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Convolution Neural Network for Malignancy Detection and Classification in Microscopic Uterine Cervix Cell Images.
    P B S; Faruqi F; K S H; Kudva R
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3447-3456. PubMed ID: 31759371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Cervical Cancer in Low-Resource African Settings.
    Mulongo M; Chibwesha CJ
    Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.